119 related articles for article (PubMed ID: 31456552)
1. Hepatitis E virus in patients with acute hepatitis in Cape Town, South Africa, 2011.
Korsman S; Hardie D; Kaba M
S Afr Med J; 2019 Jul; 109(8):582-583. PubMed ID: 31456552
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis E virus: Western Cape, South Africa.
Madden RG; Wallace S; Sonderup M; Korsman S; Chivese T; Gavine B; Edem A; Govender R; English N; Kaiyamo C; Lutchman O; van der Eijk AA; Pas SD; Webb GW; Palmer J; Goddard E; Wasserman S; Dalton HR; Spearman CW
World J Gastroenterol; 2016 Nov; 22(44):9853-9859. PubMed ID: 27956810
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands.
Tholen AT; Schinkel J; Molenkamp R; Ang CW
PLoS One; 2016; 11(2):e0146906. PubMed ID: 26840767
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
[TBL] [Abstract][Full Text] [Related]
5. A survey on the status of hepatitis e virus infection among slaughterhouse workers in South Korea.
Kim BS; Lim HS; Lee K; Min YS; Yoon YS; Jeong HS
J Prev Med Public Health; 2015 Jan; 48(1):53-61. PubMed ID: 25652711
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.
Gu G; Huang H; Zhang L; Bi Y; Hu Y; Zhou YH
BMC Infect Dis; 2015 Dec; 15():560. PubMed ID: 26653888
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.
Zhang L; Jiang Z; Lv J; Liu J; Yan B; Feng Y; Li L; Zhang G; Wang F; Xu A
BMC Infect Dis; 2018 Feb; 18(1):75. PubMed ID: 29433428
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E virus infection in different groups of Estonian patients and people who inject drugs.
Kuznetsova TV; Ivanova-Pozdejeva A; Reshetnjak I; Geller J; Värv K; Rumvolt R; Vikentjeva M; Trubnikova EV; Pozdniakova NV; Shevelev AB; Golovljova I
J Clin Virol; 2018 Jul; 104():5-10. PubMed ID: 29702351
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
[TBL] [Abstract][Full Text] [Related]
11. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.
Bortoliero AL; Bonametti AM; Morimoto HK; Matsuo T; Reiche EM
Rev Inst Med Trop Sao Paulo; 2006; 48(2):87-92. PubMed ID: 16699630
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis E virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013.
Passos-Castilho AM; de Sena A; Reinaldo MR; Granato CF
Rev Soc Bras Med Trop; 2015; 48(4):468-70. PubMed ID: 26132499
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China.
Zhu G; Qu Y; Jin N; Sun Z; Liu T; Lee H; Tian M; Wang T
Infection; 2008 Mar; 36(2):140-6. PubMed ID: 18330507
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis E virus infection in Japanese children.
Goto K; Ito K; Sugiura T; Ando T; Mizutani F; Miyake Y; Kawabe Y; Sugiyama K; Togari H
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):89-92. PubMed ID: 16385260
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
